Sean P. Duffy - 10 Dec 2025 Form 4 Insider Report for Omada Health, Inc. (OMDA)

Signature
/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy
Issuer symbol
OMDA
Transactions as of
10 Dec 2025
Transactions value $
-$142,379
Form type
4
Filing time
12 Dec 2025, 16:14:15 UTC
Previous filing
09 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Duffy Sean P. Chief Executive Officer, Director C/O OMADA HEALTH, INC., 611 GATEWAY BLVD, SUITE 120, SAN FRANCISCO /s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy 12 Dec 2025 0002069522

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMDA Common Stock Sale -$142K -9.27K -6.82% $15.37 127K 10 Dec 2025 Direct F1, F2
holding OMDA Common Stock 861K 10 Dec 2025 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by Sean P. Duffy on August 15, 2025.
F2 This transaction was executed in multiple trades at prices ranging from $15.24 to $15.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.